These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 3100656)
1. Epidermal Langerhans cells--a target for HTLV-III/LAV infection. Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656 [TBL] [Abstract][Full Text] [Related]
2. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
3. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS. Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784 [TBL] [Abstract][Full Text] [Related]
4. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487 [TBL] [Abstract][Full Text] [Related]
5. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552 [TBL] [Abstract][Full Text] [Related]
6. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934 [TBL] [Abstract][Full Text] [Related]
7. Langerhans' cells are an actual site of HIV-1 replication. Rappersberger K; Gartner S; Schenk P; Stingl G; Groh V; Tschachler E; Mann DL; Wolff K; Konrad K; Popovic M Intervirology; 1988; 29(4):185-94. PubMed ID: 3182233 [TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of the acquired immunodeficiency syndrome. Bowen DL; Lane HC; Fauci AS Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations. Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223 [TBL] [Abstract][Full Text] [Related]
11. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men. Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805 [TBL] [Abstract][Full Text] [Related]
12. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. Gartner S; Markovits P; Markovitz DM; Betts RF; Popovic M JAMA; 1986 Nov; 256(17):2365-71. PubMed ID: 3490587 [TBL] [Abstract][Full Text] [Related]
13. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States. Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178 [TBL] [Abstract][Full Text] [Related]
15. AIDS and Langerhans cells: CD4 antigenic site density modification evidenced by single-cell immunogold labeling. Gielen V; Schmitt D; Dezutter-Dambuyant C; Thivolet J Reg Immunol; 1989; 2(1):7-13. PubMed ID: 2641919 [TBL] [Abstract][Full Text] [Related]
17. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Dalgleish AG; Beverley PC; Clapham PR; Crawford DH; Greaves MF; Weiss RA Nature; 1984 Dec 20-1985 Jan 2; 312(5996):763-7. PubMed ID: 6096719 [TBL] [Abstract][Full Text] [Related]
18. Evidence for HTLV-III/LAV expression by primary cultures of T8 cells. Fouchard M; Reveil B; Mbayo K; Lurhuma A; Sarin PS; Gallo RC; Zagury D Int J Cancer; 1986 Nov; 38(5):657-9. PubMed ID: 2945790 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R; Redfield RR; Broder S J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. Kanitakis J; Marchand C; Su H; Thivolet J; Zambruno G; Schmitt D; Gazzolo L AIDS Res Hum Retroviruses; 1989 Jun; 5(3):293-302. PubMed ID: 2471543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]